|

Sertraline Clinical Trials

9 actively recruiting trials across 4 locations

Also known as: ATC code: N06AB06, Non-responder Meds, Serotonin Reuptake Inhibitor, Sertraline Hydrochloride, Zoloft

Other5 trials

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Phase 3
NMDA Modulation in Major Depressive Disorder
Phase 2
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Phase 1/2
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Phase 2
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Phase 3

Palo Alto, California1 trial

ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression

Stanford Psychiatry and Behavioral Sciences Department

Phase 2

Boston, Massachusetts1 trial

Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety

Center for Anxiety and Related Disorders at Boston University

N/A

Cincinnati, Ohio1 trial

Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.

University of Cincinnati

Phase 4

Austin, Texas1 trial

Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.